Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma Treatment

Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma Treatment

This paper reviews current treatments for renal cell carcinoma/cancer (RCC) with the multikinase inhibitors (MKIs) sorafenib, sunitinib, lenvatinib and axitinib. Furthermore, it compares these drugs regarding progression-free survival, overall survival and adverse effects (AE), with a focus on hyper...

Full description

Bibliographic Details
Main Authors: Nanna Bæk Møller, Cecilie Budolfsen, Daniela Grimm, Marcus Krüger, Manfred Infanger, Markus Wehland, Nils E. Magnusson
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:International Journal of Molecular Sciences
Subjects:
renal cell carcinoma
sorafenib
sunitinib
lenvatinib
axitinib
multikinase inhibitor
hypertension
Online Access:https://www.mdpi.com/1422-0067/20/19/4712

Internet

https://www.mdpi.com/1422-0067/20/19/4712

Similar Items